NextCure

Clinical Trial SponsorPrivate Company
Beltsville, Maryland, United States
Website
2016
Founded
50-200
Employees

About NextCure

NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

Therapeutic areas

OncologyRare DiseasesPediatrics

Browse companies by location

Beltsville, United StatesUnited States

Similar Clinical Trial Sponsor companies in United States

IGI Inc.

Clinical Trial Sponsor
New York, United States·50-200 employees

At IGI, we strive to fast-track the development of new cancer cures through collaboration. We focus on creating cutting-edge solutions to treat hematological malignancies and…

Abbott

Clinical Trial Sponsor
Chicago, United States·>5,000 employees

AbbVie Inc.

Clinical Trial Sponsor
North Chicago, United States·>5,000 employees

AffyImmune Therapeutics, Inc.

Clinical Trial Sponsor
Natick, United States·10-50 employees

AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform.